The Arab Drug Company (EGX:ADCI)

Egypt · Delayed Price · Currency is EGP

275.45

-9.56 (-3.35%)

At close: Sep 14, 2026

Market Cap	3.31B +61.8%
Revenue (ttm)	1.33B +29.3%
Net Income	229.10M +40.3%
EPS	19.09 +44.3%
Shares Out	12.00M
PE Ratio	14.43
Forward PE	n/a
Dividend	4.17 (1.41%)
Ex-Dividend Date	Oct 28, 2025

Volume	11,764
Open	285.01
Previous Close	285.01
Day's Range	267.66 - 288.99
52-Week Range	140.00 - 389.99
Beta	0.56
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations

Founded 1963

Employees 1,148

Stock Exchange Egyptian Stock Exchange

Ticker Symbol ADCI

Full Company Profile

Financial Performance

In fiscal year 2025, The Arab Drug Company's revenue was 1.12 billion, an increase of 42.35% compared to the previous year's 785.52 million. Earnings were 198.93 million, an increase of 125.18%.

Financial Statements